What is Prosoft Clinical?
Established in 1995, Prosoft Clinical operates as a comprehensive Clinical Research Organization (CRO) providing end-to-end product development and analytical services. The firm distinguishes itself through a specialized focus on pharmaceutical ANDA, 505(b)(2), and NDA pathways, alongside rigorous support for 510(k) and PMA medical device programs. By integrating proprietary electronic data capture and management systems, Prosoft Clinical delivers high-efficiency, data-driven solutions. Their team of seasoned industry professionals provides critical regulatory, statistical, and clinical expertise, ensuring that sponsors navigate complex development lifecycles with precision and speed. The company remains a vital partner for organizations seeking to optimize their path to market through tailored, high-quality research support.
How much funding has Prosoft Clinical raised?
Prosoft Clinical has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Prosoft Clinical
PPP
Public-Private Partnership
What's next for Prosoft Clinical?
With the successful completion of this late-stage financing, Prosoft Clinical is strategically positioned to scale its infrastructure and enhance its technological suite. The firm is expected to prioritize the expansion of its internal data management capabilities, ensuring that it remains at the forefront of clinical trial efficiency. As the regulatory environment for medical devices and pharmaceuticals continues to evolve, Prosoft Clinical will likely utilize this capital to deepen its regulatory consulting expertise and broaden its geographic footprint. This growth trajectory suggests a focus on long-term sustainability and the continued delivery of high-value, rapid-turnaround services for its diverse client base, solidifying its reputation as a cornerstone of the clinical development ecosystem.
See full Prosoft Clinical company page
